Director's Dealing • Dec 21, 2017
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 1002A
Surgical Innovations Group PLC
21 December 2017
Surgical Innovations Group plc
("SI Group" or the "Company")
Issue of Shares
Surgical Innovations Group plc (AIM: SUN) has issued and allotted a total of 202,759 ordinary shares of 1p each ("Shares") at a price of 3.625p per share to Nigel Rogers, Executive Chairman, and Michael McMahon, Non-Executive Director in lieu of remuneration for the fourth quarter of 2017.
Details of the Shares issued and the resulting holdings of each of the directors are as follows:
| Director | Shares issued | Resulting holding | Percentage of enlarged share capital |
| Nigel Rogers | 120,000 | 5,541,060 | 0.71% |
| Michael McMahon | 82,759 | 18,669,129 | 2.39% |
The issue price was set at the closing price on the date of the Company's payroll in December.
Application will be made for 202,759 Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 29 December 2017.
Following Admission, the total number of ordinary shares in issue will be 782,566,177 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of calculating their holding in the Company under the Disclosure Guidance and Transparency Rules.
For further information please contact:
| Surgical Innovations Group plc | www.sigroupplc.com |
| Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
| Melanie Ross, COO & CFO | |
| WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
| Tim Feather | |
| Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or [email protected] |
| Paul McManus | Mob: 07980 541 893 |
| Lianne Cawthorne | Mob: 07584 391 303 |
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Nigel Rogers
2
Reason for the notification
a)
Position/status
Executive Chairman
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Shares in lieu of remuneration
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.625p | 120,000 |
d)
Aggregated information
- Aggregated volume
- Price
120,000
£4,350
e)
Date of the transaction
29th December 2017
f)
Place of the transaction
Not on exchange
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Michael McMahon
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
2138004GHGUH3HUZE156
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
Shares in lieu of remuneration
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.625p | 82,759 |
d)
Aggregated information
- Aggregated volume
- Price
82,759
£3,000
e)
Date of the transaction
29th December 2017
f)
Place of the transaction
Not on exchange
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLFLFLDLFFFBF
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.